Cargando…
A Mixture Method for Robust Detection HCV Early Diagnosis Biomarker with ML Approach and Molecular Docking
Given the substantial correlation between early diagnosis and prolonged patient survival in HCV patients, it is vital to identify a reliable and accessible biomarker. The purpose of this research was to identify accurate miRNA biomarkers to aid in the early diagnosis of HCV and to identify key targe...
Autores principales: | Gholizadeh, Maryam, Łapczuk-Romańska, Joanna, Post, Mariola, Komaniecka, Nina, Mazlooman, Seyed Reza, Kaderali, Lars, Droździk, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138470/ https://www.ncbi.nlm.nih.gov/pubmed/37108370 http://dx.doi.org/10.3390/ijms24087207 |
Ejemplares similares
-
Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure
por: Szeląg-Pieniek, Sylwia, et al.
Publicado: (2021) -
Kidney Drug Transporters in Pharmacotherapy
por: Łapczuk-Romańska, Joanna, et al.
Publicado: (2023) -
Detection of key mRNAs in liver tissue of hepatocellular carcinoma patients based on machine learning and bioinformatics analysis
por: Gholizadeh, Maryam, et al.
Publicado: (2023) -
Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology
por: Drozdzik, Marek, et al.
Publicado: (2021) -
Identifying Differentially Expressed MicroRNAs, Target Genes, and Key Pathways Deregulated in Patients with Liver Diseases
por: Gholizadeh, Maryam, et al.
Publicado: (2020)